Type I Diabetes Mellitus impairs cytotoxic immunity through CEACAM5 upregulation in colorectal cancer: Exploring the intersection of autoimmune dysfunction and cancer progression: the role of NF-κB p65 in colorectal cancer.

MLA

Yingying, Li, et al. “Type I Diabetes Mellitus Impairs Cytotoxic Immunity through CEACAM5 Upregulation in Colorectal Cancer: Exploring the Intersection of Autoimmune Dysfunction and Cancer Progression: The Role of NF-ΚB P65 in Colorectal Cancer.” Journal of Molecular Histology, vol. 55, no. 6, Dec. 2024, pp. 1285–93. EBSCOhost, https://doi.org/10.1007/s10735-024-10269-3.

APA

Yingying, L., Xingyong, F., Deying, Z., Xingchen, T., Jiahua, Z., & Jie, Y. (2024). Type I Diabetes Mellitus impairs cytotoxic immunity through CEACAM5 upregulation in colorectal cancer: Exploring the intersection of autoimmune dysfunction and cancer progression: the role of NF-κB p65 in colorectal cancer. Journal of Molecular Histology, 55(6), 1285–1293. https://doi.org/10.1007/s10735-024-10269-3

Chicago

Yingying, Li, Feng Xingyong, Zhao Deying, Tian Xingchen, Zou Jiahua, and Yu Jie. 2024. “Type I Diabetes Mellitus Impairs Cytotoxic Immunity through CEACAM5 Upregulation in Colorectal Cancer: Exploring the Intersection of Autoimmune Dysfunction and Cancer Progression: The Role of NF-ΚB P65 in Colorectal Cancer.” Journal of Molecular Histology 55 (6): 1285–93. doi:10.1007/s10735-024-10269-3.